Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM
| Authors |
Leila Ronceray Oussama Abla Shlomit Barzilai-Birenboim Simon Bomken Alan Ks Chiang Janez Jazbec Edita Kabickova Jelena Lazic Auke Beishuizen Karin Mellgren Fumiko Tanaka Marta Pillon Christine Devalck Marina Gouttenoire Olga Makarova Birgit Burkhardt Andishe Attarbaschi |
|---|---|
| Published in | Pediatric blood & cancer |
| Volume | 65 |
| Issue | 4 |
| Pages | e26932 |
| ISSN | 1545-5017 |
| Publication year | 2018 |
| Published at |
Institute of Clinical Sciences, Department of Pediatrics |
| Pages | e26932 |
| Language | en |
| Links |
dx.doi.org/10.1002/pbc.26932 www.ncbi.nlm.nih.gov/entrez/query.f... |
| Keywords | complete resection; marginal zone lymphoma; outcome; watch-and-wait |
| Subject categories | Pediatrics |
Data on management of pediatric marginal zone lymphoma (MZL) are scarce. This retrospective study assessed characteristics and outcome in 66 patients who were <18 years old. Forty-four (67%) had an extranodal MZL (EMZL), 21 (32%) a nodal MZL (NMZL), and one patient a splenic MZL. Thirty-three patients (50%) received a variable combination of adjuvant chemotherapy/immunotherapy/radiotherapy, while the remainder, including 20 of 21 with NMZL, entered an active observation period. Overall survival was excellent (98 ± 2%), although 11 patients relapsed (17%; NMZL, n = 1; EMZL, n = 10), seven after any therapy and four after complete resection only. In conclusion, outcome of NZML, in particular, seems to be excellent after (in)complete resection and observation only.
© UNIVERSITY OF GOTHENBURG • Sweden • Box 100 • SE-405 30 Gothenburg
Phone: +46 31 786 0000 • Contact • Organisation number: 202100-3153
About the website
Facebook
Twitter
Instagram
Youtube
Weibo